FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称BELUDAVIMAB
异名/同义词BELUDAVIMAB
BELUDAVIMAB [INN]
BELUDAVIMAB [USAN]
GSK4182137
GSK-4182137
IMMUNOGLOBULIN G1 (246-ALANINE,340-LEUCINE,342-GLUTAMIC ACID,438-LEUCINE,444-SERINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL VIR-7832 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VIR-7832 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) GLYCOPROTEIN, RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-457) (VH (HOMO SAPIENS IGHV1-18*01 (92.9%)-(IGHD)-IGHJ5*01 (92.9%), CDR-IMGT (8.8.20) (26-33.51-58.97-116)) (1-127)-HOMO SAPIENS IGHG1*01, G1M17,1, G1V12 CH2 A1.1, L115, E117, G1V24 CH3 L107, S114 (CH1 K120 (224) (128-225), HINGE 1-15 (226-240), CH2 G1.1>A (246), A115>L (340), I117>E (342) (241-350), CH3 D12 (366), L14 (368), M107>L (438), N114>S (444) (351-455), CHS (456-457)) (128-457)), (230-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA (HOMO SAPIENS IGKV3-20*01 (93.7%)-IGKJ4*01 (100%), CDR-IMGT (7.3.8) (27-33.51-53.90-97)) (1'-107')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (236-236'':239-239'')-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO)-K1 CELL LINE, GLYCOFORM ALFA
VIR 7832 [WHO-DD]
VIR7832
VIR-7832
CAS登记号2423016-74-2
物质唯一标识(Unique Ingredient Identifier)FM2MK5954W
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System